Organ Preservation Solution Market to Reach USD 785 Million by 2034 at 9.7% CAGR | DelveInsight

DelveInsight's "Organ Preservation Solution Market Insights, Size, and Forecast 2034" report delivers an in-depth understanding of the organ preservation solution market trends, growth drivers, restraints, competitive landscape, and regional dynamics across North America, Europe, Asia-Pacific, and the Rest of the World.

Explore the intricate details of the Organ Preservation Solution Market Report @ https://www.delveinsight.com/report-store/organ-preservation-solution-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=akpr

Key Takeaways from Organ Preservation Solution Market Report
• The global organ preservation solution market is estimated at USD 340 million in 2025 and is projected to reach USD 785 million by 2034, expanding at a CAGR of 9.7% during 2026-2034.
• By product/solution type, the organ preservation solutions segment dominated the market with a 61% share in 2025.
• By application, the preservation segment held the leading position with a 38% market share in 2025.
• By organ type, the kidney segment dominated the market with a 42% share in 2025.
• North America dominated the global market with a 41% share in 2025, representing the highest regional market share globally, while Asia-Pacific is projected to be the fastest-growing region through 2034.
• The United States performed 48,149 total organ transplants in 2024, nearly 132 procedures per day, including 27,759 kidney transplants, 11,458 liver transplants, and 4,572 heart transplants.
• In October 2025, Bridge to Life received FDA 510(k) clearance for multi-sourced Belzer UW® and MPS® solutions, with expanded labeling letting Belzer MPS® support hypothermic machine perfusion across all abdominal organs, a first for the field.
• Key Organ Preservation Solution Companies include Bridge to Life Ltd., XVIVO Perfusion AB, Institut Georges Lopez (IGL), Dr. Franz Köhler Chemie GmbH, Organ Recovery Systems, TransMedics, Inc., OrganOx Limited, Preservation Solutions, Inc., Essential Pharmaceuticals LLC, Paragonix Technologies, and others.

Get a Free sample for the Organ Preservation Solution Market Forecast, Size & Share Analysis Report @ https://www.delveinsight.com/sample-request/organ-preservation-solution-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=akpr

What is Organ Preservation Solution?
Organ Preservation Solution is a sterile biochemical formulation designed to maintain donor organ viability, structure, and function between recovery and transplantation. It reduces ischemic injury by lowering cellular metabolism, limiting edema, maintaining electrolyte and pH balance, neutralizing free radicals, and protecting cell membranes. Key formulations include UW, HTK, Celsior, IGL, and Perfadex®. Selection depends on organ type, preservation method, ischemic duration, and clinical requirements.

Organ Preservation Solution Market Segmentation
• Product/Solution Type: Organ Preservation Solutions (UW Solution, HTK Solution, Celsior Solution, IGL-1 Solution, Perfadex, EuroCollins/Collins Solution, and Others) and Perfusion Solutions/Machine Perfusion (Hypothermic Machine Perfusion (HMP) Solutions, Hypothermic Oxygenated Perfusion (HOPE/D-HOPE) Solutions, Normothermic Machine Perfusion (NMP) Solutions, Subnormothermic/Controlled Oxygenated Rewarming Solutions, and Other Proprietary Perfusion Solutions)
• Application: Procurement, Preservation, Transportation, Pre-Implantation, and Post-Implantation
• Organ Type: Kidney, Liver, Heart, Pancreas, and Others
• Geography: North America, Europe, Asia-Pacific, Rest of World

Download the report to understand which factors are driving organ preservation solution market trends @ https://www.delveinsight.com/report-store/organ-preservation-solution-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=akpr

Organ Preservation Solution Market Key Growth Drivers
• The rising number of organ transplantation procedures worldwide is significantly driving demand for Organ Preservation Solutions, supported by increasing kidney, liver, heart, lung, and pancreas transplant volumes and expanding transplant programs across developed and emerging economies.
• The growing shortage of donor organs is accelerating the adoption of advanced preservation solutions that extend organ viability, reduce ischemia-reperfusion injury, and improve graft utilization, thereby increasing the success rate of transplantation.
• The increasing prevalence of end-stage organ failure and chronic diseases, including Chronic Kidney Disease, Liver Cirrhosis, Heart Failure, and chronic lung diseases, is expanding the global transplant candidate pool and fueling demand for effective organ preservation technologies.
• Continuous advancements in hypothermic machine perfusion (HMP), normothermic machine perfusion (NMP), and ex vivo organ perfusion systems are boosting the use of specialized preservation solutions optimized for dynamic perfusion, improving organ quality and post-transplant outcomes.
• Rising investments by governments, transplant organizations, and healthcare institutions in organ donation awareness programs, transplant infrastructure, and organ procurement networks are increasing the number of donor organs recovered and preserved, supporting market growth.

Organ Preservation Solution Market Restraints
Machine perfusion solutions and the platforms that deliver them carry substantially higher costs than conventional static cold storage, which can limit adoption among smaller transplant centers and in cost-constrained healthcare systems. The short viable window of donor organs imposes severe time and logistics constraints, requiring precise cold-chain handling and rapid transportation that can be difficult to guarantee across long distances or in regions with underdeveloped transplant infrastructure.

Regulatory approval pathways for new preservation and perfusion chemistries can be lengthy, as illustrated by delays in CE certification for novel heart preservation solutions pending additional scientific review. Reimbursement for machine perfusion remains uneven across geographies, and a shortage of personnel trained in perfusion techniques constrains scale-up at transplant centers seeking to adopt newer technologies.

Global supply-chain fragility, including periodic delivery constraints for certain branded preservation solutions, can disrupt availability, while the persistent gap between organ demand and donor supply continues to cap the addressable procedure volume in many countries.

Organ Preservation Solution Companies
Bridge to Life Ltd., XVIVO Perfusion AB, Institut Georges Lopez (IGL), Dr. Franz Köhler Chemie GmbH, Organ Recovery Systems, TransMedics, Inc., OrganOx Limited, Preservation Solutions, Inc., Essential Pharmaceuticals LLC, Paragonix Technologies.

Discover more about companies set to grab major Organ Preservation Solution market share @ https://www.delveinsight.com/sample-request/organ-preservation-solution-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=akpr

Organ Preservation Solution Market Outlook
North America led the global market in 2025, capturing 41% of revenue, driven by high transplant volumes, extensive transplant networks, and supportive FDA pathways. Europe remains a mature market, supported by established manufacturers and coordinated regulatory systems. Asia-Pacific is the fastest-growing region, fueled by rising organ failure, expanding transplant infrastructure, and healthcare investment. Meanwhile, Latin America, the Middle East, and Africa offer emerging opportunities as healthcare infrastructure develops and transplant capabilities improve.

Scope of the Organ Preservation Solution Market Report
• Product/Solution Type: Organ Preservation Solutions and Perfusion Solutions/Machine Perfusion
• Application: Procurement, Preservation, Transportation, Pre-Implantation, and Post-Implantation
• Organ Type: Kidney, Liver, Heart, Pancreas, and Others
• Coverage: North America, Europe, Asia-Pacific, and Rest of World
• Organ Preservation Solution Companies: Bridge to Life Ltd., XVIVO Perfusion AB, Institut Georges Lopez (IGL), Dr. Franz Köhler Chemie GmbH, Organ Recovery Systems, TransMedics, Inc., OrganOx Limited, Preservation Solutions, Inc., Essential Pharmaceuticals LLC, Paragonix Technologies, and others
• Organ Preservation Solution Market Segmentation: By Product/Solution Type, Application, Organ Type, and Geography
• Organ Preservation Solution Market Dynamics: Market drivers and market restraints
• Competitive Landscape Analysis: Market concentration, leading players, geographic reach, product portfolio strength, regulatory access, strategic partnerships, M&A activity, manufacturing capabilities, and innovation focus

To know more about organ preservation solution companies working in the market, visit @ https://www.delveinsight.com/sample-request/organ-preservation-solution-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=akpr

Table of Contents
1. Organ Preservation Solution Market Report Introduction
2. Organ Preservation Solution Market Executive Summary
3. Organ Preservation Solution Market Key Factors Analysis
4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
5. Regulatory Analysis
6. Organ Preservation Solution Market Porter's Five Forces Analysis
7. Organ Preservation Solution Market Assessment
8. Organ Preservation Solution Market Competitive Landscape
9. Organ Preservation Solution Market Startup Funding and Investment Trends
10. Organ Preservation Solution Market Company and Product Profiles
11. KOL Views
12. Project Approach
13. About DelveInsight
14. Disclaimer and Contact Us

Company Name: DelveInsight Business Research LLP
Contact Person: Abhishek kumar
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com

About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

This release was published on openPR.